TrialBritish journal of haematology2012

Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents.

Merav Leiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.